3B Blackbio [3BBLACKBIO] vs OneSource Specialty [ONESOURCE] Detailed Stock Comparison

3B Blackbio Diagnostics Ltd.

BSE
Loading...

OneSource Specialty Pharma Inc.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: 3B Blackbio Diagnostics Ltd. wins in 14 metrics, OneSource Specialty Pharma Inc. wins in 3 metrics, with 0 ties. 3B Blackbio Diagnostics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric 3B Blackbio Diagnostics Ltd. OneSource Specialty Pharma Inc. Better
P/E Ratio (TTM) 20.80 936.63 3B Blackbio Diagnostics Ltd.
Price-to-Book Ratio 3.89 3.11 OneSource Specialty Pharma Inc.
Debt-to-Equity Ratio 0.09 21.93 3B Blackbio Diagnostics Ltd.
PEG Ratio 0.34 42.24 3B Blackbio Diagnostics Ltd.
EV/EBITDA 20.17 40.79 3B Blackbio Diagnostics Ltd.
Profit Margin (TTM) 44.56% 1.42% 3B Blackbio Diagnostics Ltd.
Operating Margin (TTM) 42.39% -18.02% 3B Blackbio Diagnostics Ltd.
EBITDA Margin (TTM) 42.39% N/A N/A
Return on Equity 17.60% -0.31% 3B Blackbio Diagnostics Ltd.
Return on Assets (TTM) 16.13% -0.24% 3B Blackbio Diagnostics Ltd.
Free Cash Flow (TTM) $424.53M $-1.96B 3B Blackbio Diagnostics Ltd.
1-Year Return -24.89% -5.07% OneSource Specialty Pharma Inc.
Price-to-Sales Ratio (TTM) 9.21 13.01 3B Blackbio Diagnostics Ltd.
Enterprise Value $11.32B $195.90B OneSource Specialty Pharma Inc.
EV/Revenue Ratio 8.78 13.80 3B Blackbio Diagnostics Ltd.
Gross Profit Margin (TTM) 72.47% 67.50% 3B Blackbio Diagnostics Ltd.
Revenue per Share (TTM) $152 $124 3B Blackbio Diagnostics Ltd.
Earnings per Share (Diluted) $66.57 $1.72 3B Blackbio Diagnostics Ltd.
Beta (Stock Volatility) 0.47 N/A N/A

3B Blackbio Diagnostics Ltd. vs OneSource Specialty Pharma Inc. Stock Performance Analysis

Loading Price Chart...

3BBLACKBIO
ONESOURCE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
3B Blackbio Diagnostics Ltd.-0.73%-7.13%-9.11%-6.85%-11.83%-19.55%
OneSource Specialty Pharma Inc.1.51%1.08%3.09%35.60%9.83%1.28%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
3B Blackbio Diagnostics Ltd.-24.89%58.97%58.97%58.97%58.97%58.97%
OneSource Specialty Pharma Inc.-5.07%6.70%6.70%6.70%6.70%6.70%

Performance & Financial Health Analysis: 3B Blackbio Diagnostics Ltd. vs OneSource Specialty Pharma Inc.

Metric3BBLACKBIOONESOURCE
Market Information
Market Cap i₹11.13B₹202.76B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i12,5081,038,625
90 Day Avg. Volume i12,860610,058
Last Close₹1,129.75₹1,837.90
52 Week Range₹1,083.50 - ₹1,750.00₹1,057.00 - ₹2,248.00
% from 52W High-35.44%-18.24%
All-Time High₹2,350.00 (Dec 09, 2024)₹2,248.00 (Jun 18, 2025)
% from All-Time High-51.93%-18.24%
Growth Metrics
Quarterly Revenue Growth0.98%-0.26%
Quarterly Earnings Growth0.62%N/A
Financial Health
Profit Margin (TTM) i0.45%0.01%
Operating Margin (TTM) i0.42%-0.18%
Return on Equity (TTM) i0.18%0.00%
Debt to Equity (MRQ) i0.0921.93
Cash & Liquidity
Book Value per Share (MRQ)₹355.75₹518.08
Cash per Share (MRQ)₹27.44₹14.56
Operating Cash Flow (TTM) i₹619.97M₹-2,152,760,000
Levered Free Cash Flow (TTM) i₹476.91M₹-179,710,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: 3B Blackbio Diagnostics Ltd. vs OneSource Specialty Pharma Inc.

Metric3BBLACKBIO (Apr 24, 2026)ONESOURCE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i20.80936.63
Forward P/E iN/A42.24
PEG Ratio i0.3442.24
Price to Sales (TTM) i9.2113.01
Price to Book (MRQ) i3.893.11
Market Capitalization
Market Capitalization i₹11.13B₹202.76B
Enterprise Value i₹11.32B₹195.90B
Enterprise Value Metrics
Enterprise to Revenue i8.7813.80
Enterprise to EBITDA i20.1740.79
Risk & Other Metrics
Beta i0.47N/A
Book Value per Share (MRQ) i₹355.75₹518.08

Financial Statements Comparison: 3B Blackbio Diagnostics Ltd. vs OneSource Specialty Pharma Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric3BBLACKBIO (2025)ONESOURCE (2025)
Revenue/Sales i964.69M14.45B
Cost of Goods Sold i256.46M4.35B
COGS % of Revenue i26.6%30.1%
Gross Profit i708.23M10.10B
Gross Margin i73.4%69.9%
Research & Development i5.12M20.49M
Operating Income (EBIT) i493.22M1.90B
Operating Margin i51.1%13.2%
EBITDA i591.08M4.71B
EBITDA Margin i61.3%32.6%
Pre-Tax Income i639.98M-670.66M
Pre-Tax Income % of Revenue i66.3%-4.6%
Income Tax i163.07M-497.85M
Income Tax % of Revenue i16.9%-3.4%
Net Income (Profit) i476.91M-179.71M
Profit Margin i49.4%-1.2%

Balance Sheet & Liquidity Metrics

Metric3BBLACKBIO (2025)ONESOURCE (2025)
Cash & Equivalents i117.07M1.56B
Total Current Assets i1.32B10.86B
Total Current Assets % of Revenue i137.0%75.2%
Total Current Liabilities i185.88M11.14B
Total Current Liabilities % of Revenue i19.3%77.1%
Long-Term Debt i3.07M3.83B
Long-Term Debt % of Revenue i0.3%26.5%
Total Shareholders Equity i2.71B58.81B
Retained Earnings i2.51B-18.43B
Retained Earnings % of Revenue i259.9%-127.6%
Property, Plant & Equipment i85.37M8.97B

Cash Flow Statement Comparison

Metric3BBLACKBIO (2025)ONESOURCE (2025)
Operating Cash Flow i619.97M-2.15B
Operating Cash Flow % of Revenue i64.3%-14.9%
Capital Expenditures i-9.04MN/A
Free Cash Flow i424.53M-1.96B
FCF Margin i44.0%-13.6%
Debt Repayment i-5.44M-6.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

Metric3BBLACKBIOONESOURCE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.58M114.64M
Float Shares i2.69M70.43M
% Held by Insiders i65.90%38.63%
% Held by Institutions i1.95%26.67%
% Held by Public i32.15%34.70%

Dividend Analysis & Yield Comparison: 3B Blackbio Diagnostics Ltd. vs OneSource Specialty Pharma Inc.

Metric3BBLACKBIOONESOURCE
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A